Dr. Felix Wagner

Dr. Felix Wagner's work experience includes roles as a Principal Scientist Protein Therapeutics at Odyssey Therapeutics starting in 2022, a Postdoctoral Researcher at the Max Planck Institute for Biophysical Chemistry from 2015 to 2021, a Doctoral Researcher at the Max Planck Institute for Biophysical Chemistry from 2015 to 2019, an Undergraduate Research Assistant at Ludwig-Maximilians Universität München in 2014, a Research Intern at Boehringer Ingelheim from 2013 to 2014, an Undergraduate Teaching Assistant at the University of Tübingen in 2012, and an Undergraduate Research Assistant at the Max Planck Institute for Developmental Biology from 2011 to 2012.

Dr. Felix Wagner holds a Ph.D. in Structural Biology from The University of Göttingen, which they obtained from 2015 to 2019. Prior to that, they pursued a Master of Science degree in Structural Biology at UC San Diego from 2014 to 2015. Dr. Wagner also completed their Master of Science in Biochemistry at Ludwig-Maximilians-Universität München from 2012 to 2015, following a Bachelor of Science degree in Biochemistry at the University of Tübingen from 2009 to 2012. Additionally, they obtained a certification in Good Manufacturing Practice from GMP Kurs in an unspecified year.